诺华iptacopan治疗IgA肾病2期临床达到主要终点( 二 )


【诺华iptacopan治疗IgA肾病2期临床达到主要终点】参考来源:Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy (IgAN)